Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Skin-derived stem cells treat Parkinson's disease in rats

14 April 2008

By Evelyn Harvey

Appeared in BioNews 453

Nerve tissue derived from stem cells made from reprogrammed skin developed into normal brain tissue and relieved symptoms of Parkinson's disease in rats, in a study published in the journal Proceedings of the National Academy of Sciences of the USA (PNAS) last week. Scientists at the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts and the Massachusetts Institute of Technology, US, showed for the first time that nerves developed from so-called induced pluripotent stem cells (iPS cells) can form functional brain tissue.

Last year, the group were among the first to develop iPS cells by treating mouse skin cells with a combination of genetic factors. Two independent groups then successfully generated human iPS cells. These cells resemble embryonic stem cells (ES cells) and can develop into different body tissues, but do not require the creation and destruction of an embryo.

'These cells are more readily available and much less controversial than embryonic stem cells. But they seem to have identical potential', said team leader Rudolf Jaenisch last year.
In the latest study, Jaenisch, Marius Wernig and colleagues first developed nerve precursor cells from iPS cells and transplanted them into the brains of developing mice. After nine weeks, the iPS-derived cells had migrated and grown into several distinct subtypes of nerve tissue in the brains of the newborn mice.

'They were all over the place and they were electrically integrated. They looked like they were really functional cells', explained Jaenisch.

Motion difficulties in Parkinson's disease arise from a lack of the brain signalling chemical dopamine, due to the death of dopamine-producing neurons. The researchers made iPS cells develop into dopamine neurons, and used them to treat rats given symptoms of Parkinson's disease. The rats' dopamine neurons were chemically damaged in the striatum, an area of the brain involved in motion control, leading to difficulties in balancing and walking. Of the nine rats in the study, eight showed marked improvement in motion and dopamine activity four weeks after the differentiated cells were transplanted.

'This is the first demonstration that reprogrammed cells can integrate into the neural system or positively affect neurodegenerative disease', Wernig said.

'These iPS cells could be used for generating functional dopaminergic neurons that could have therapeutic value', added Jaenisch.

Since iPS cells can be created by reprogramming cells from patients, the potential for individually targeted stem cell therapy for Parkinson's disease is highlighted by this research. However, experimental grafting cannot yet be performed in humans. The genetic factors used to generate iPS cells could lead to tumour formation, and the safety of the viral vectors used in their production is also unknown. Finally, the rat model of Parkinson's disease does not precisely mimic the complex processes of the condition in humans. Further development of the techniques used to create iPS cells will be necessary, it seems, before their medical applications can be realised.

SOURCES & REFERENCES
The Boston Globe | 08 April 2008
 
Medical News Today | 07 April 2008
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

16 April 2012 - by Dr Kimberley Bryon-Dodd 
A woman with Parkinson's disease is reportedly able to write again for the first time in 15 years after receiving pioneering gene therapy at Addenbrooke's Hospital, Cambridge. Mrs Shelia Roy took part in an early stage clinical trial of ProSavin - a treatment developed by biopharmaceutical company, Oxford BioMedica....
06 February 2012 - by Cathy Holding 
Mouse skin cells have been converted directly into neural precursor cells which go on to form the major cells in the brain...
18 July 2011 - by Dr Lux Fatimathas 
US researchers have successfully converted human skin cells directly into brain nerve cells, skipping an intermediate stem cell stage. The new technique has the potential to aid research into neurodegenerative disorders of the brain, such as Parkinson's and Alzheimer's....
20 July 2009 - by Dr Will Fletcher 
Induced pluripotent stem (iPS) cells have been used to repair damaged heart tissue in mice by a team from the Mayo Clinic in Rochester, Minnesota, US. iPS cells are adult cells that are reprogrammed to act like embryonic stem cells - in this case the iPS cells were derived from ordinary fibroblasts (cells that contribute to scars such as those resulting from a heart attack). When the cells were injected into mice whose hearts had been damaged by a heart attack they improved both...
01 September 2008 - by Dr Rebecca Robey 
Researchers at the Harvard Stem Cell Institute in Boston, USA, have successfully transformed one type of adult cell in to another cell type in live mice, according to a study published in the journal Nature. The cells created were insulin-producing beta cells of the pancreas - the cells...

26 March 2008 - by Katy Sinclair 
A study in Nature Medicine, by the Memorial Sloan-Kettering Cancer Centre Team, has reported the successful treatment of mice with Parkinson's disease using 'therapeutic cloning', giving hope that one day a similar treatment could treat people with the condition. In an important 'proof of concept' study for...
27 January 2008 - by Dr Rebecca Robey 
Researchers at the University of Texas Southwestern Medical Centre have developed a new technique to treat the symptoms of muscular dystrophy using embryonic stem (ES) cells. The group, reporting in the February 2008 issue of Nature Medicine, successfully manipulated mouse ES cells to transform them into muscle-forming...
21 January 2008 - by MacKenna Roberts 
Scientists at the California biotechnology company, Stemagen, announced last week that they had successfully cloned the world's first human embryos, created from adult male skin cells. Although British scientists cloned human embryos two years ago, this is the first time that scientists have managed to grow such...
26 November 2007 - by Dr Jess Buxton 
Two groups of scientists have managed to 'reprogramme' skin cells, retuning them to an embryonic-like state in which they regain the potential to develop into any type of body cell. The studies, published in the journals Cell and Science, pave the way for new research aimed...
12 November 2007 - by Katy Sinclair 
Scientists from the University of California have announced findings that stem cell injections could restore memory lost through strokes or neurodegenerative diseases. Publishing in the Journal of Neuroscience, the team hopes that in the future stem cells may be able to restore the memory of people suffering...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation